Neuropathology Core
- Institution
- Mayo Clinic Rochester, MN
- Principal investigator
- William W Seeley
- Funding
- $584K
- Duration
- 2019–2030
Moonbase score
Still being scored
Abstract
ABSTRACT – ALLFTD2: NEUROPATHOLOGY CORE Neuropathology remains the gold standard for neurodegenerative disease diagnosis, and the overall goals of the ALLFTD consortium are strongly linked to post-mortem characterization of each patient’s disease. Despite some progress, it remains difficult to predict the underlying neuropathological diagnosis in patients with FTLD. Ongoing efforts seek to uncover disease-specific biofluid and molecular imaging biomarkers for sorting patients into pathologically homogeneous, clinical trial-ready cohorts. Developing such biomarkers relies on neuropathology not only to provide a diagnostic gold standard but also as a source of biomarker discovery- enabling tissue. Moreover, post-mortem tissue provides a rich source of fundamental information about disease pathogenesis. The goals of this ALLFTD Neuropathology Core (NPC) are to support the clinical, genetic, imaging, and biomarker research efforts throughout the ALLFTD network and worldwide. We will build on momentum gained during the previous cycle by deploying our distributed network of neuropathology sites equipped for FTLD diagnosis to provide the diagnostic gold standard against which in vivo diagnostic biomarkers are measured. Researchers developing these biomarkers will benefit from ultimately learning each patient’s underlying disease, which may influence the behavior of any biomarker type. For these reasons, this NPC will strive to obtain a state-of-the-art neuropathological diagnosis on every ALLFTD participant who dies during the study period. The NPC will work with ALLFTD investigators in the Clinical, Technology and Remote Assessment, Data Management and Statistical, Genetics, Neuroimaging, and Biofluid Cores and Projects 1 and 2 to support the proposed ALLFTD studies. Increasingly, pathological correlation studies require active multidisciplinary interactions that include neuropathology experts who can ensure that neuropathological data are analyzed and interpreted in a way that keeps pace with the constantly evolving knowledge in the field.
LOADING MOONBASE SCORE
Questions for Mayo Clinic Rochester
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of California, San FranciscoNot yet scored
Core D - Neuropathology Core
William W Seeley · $574K · 2019–2029
- NIH · University of California, San FranciscoNot yet scored
Upstream pathogenesis in familial and sporadic frontotemporal dementia and motor neuron disease
William W Seeley · $3.2M · 2018–2029
- NIH · University of California, San FranciscoNot yet scored
Neuropathology
William W Seeley · $360K · 2002–2028